Connect your AI

SiriusPoint SPNT Net unrealized losses

Net unrealized losses at other companies

SeaboardSEB

-$5M+58.3%

Catalyst PharmaceuticalCPRX

$8K+110%

Crinetics PharmaceuticalsCRNX

-$3.15M-405%

Assured GuarantyAGO

$6M+500%

First BanCorpFBP

-$6.17M-107%

Arcutis Biotherapeutics, Inc.ARQT

-$351K-156%

Other financials

Income statement

Revenue$774.6M+6.5%

Net income$102.2M+65.9%

EPS (diluted)$0.82+67.3%

Balance sheet

Cash & equivalents$1.0B+9.2%

Total debt$702.9M+2.2%

Total equity$2.3B+13.7%

Total assets$12.5B+1.6%

Cash flow

Operating cash flow$141.9M+260%

Valuation

Market cap$2.78B+25.6%

Enterprise value$2.47B+25.1%

P/E5.6×-6.5×

P/S0.9×0.0×

Profitability

Net margin15.4%+8.4pp

Returns & leverage

Return on equity23.1%+15.2pp

Debt / equity0.3×0.0×

Where this comes from

Reported directly by SiriusPoint in its filing.

Tagged under the XBRL concept us-gaap:DebtSecuritiesTradingUnrealizedGainLoss.

The official record: SiriusPoint’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about SiriusPoint's net unrealized losses.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is SiriusPoint's net unrealized losses?: SiriusPoint (SPNT) reported net unrealized losses of -$1.6M in Q1 2026.
How has SiriusPoint's net unrealized losses changed year-over-year?: SiriusPoint's net unrealized losses decreased by 188.9% year-over-year, from $1.8M to -$1.6M.